8 Charts That Show How Ethnicity Determines Your Outcome at University
https://www.buzzfeed.com/tomphillips/this-is-what-you-need-to-know-about-diversity-in-the-uks?utm_term=.un35k1RYx#.vnQ9QDkw0
♨ Daily Geek News Here @dailygeeknews
#8 #Charts #That #Show #How #Ethnicity #Determines #Your #Outcome #at #University
https://www.buzzfeed.com/tomphillips/this-is-what-you-need-to-know-about-diversity-in-the-uks?utm_term=.un35k1RYx#.vnQ9QDkw0
♨ Daily Geek News Here @dailygeeknews
#8 #Charts #That #Show #How #Ethnicity #Determines #Your #Outcome #at #University
BuzzFeed
This Is What You Need To Know About Diversity In The UK's University System
White people are the least likely to go to university – but some BAME students still face disadvantages throughout the process.
FDA Delays Moderna Vaccine for Adolescents to Review Rare Myocarditis Outcome
https://www.wsj.com/articles/fda-delays-moderna-covid-19-vaccine-for-adolescents-to-review-rare-myocarditis-side-effect-11634315159
♨️ Daily Geek News Here @dailygeeknews
#FDA #Delays #Moderna #Vaccine #for #Adolescents #to #Review #Rare #Myocarditis #Outcome
https://www.wsj.com/articles/fda-delays-moderna-covid-19-vaccine-for-adolescents-to-review-rare-myocarditis-side-effect-11634315159
♨️ Daily Geek News Here @dailygeeknews
#FDA #Delays #Moderna #Vaccine #for #Adolescents #to #Review #Rare #Myocarditis #Outcome
WSJ
WSJ News Exclusive | FDA Delays Moderna Covid-19 Vaccine for Adolescents to Review Rare Myocarditis Side Effect
Moderna asked the Food and Drug Administration in June to expand use of the company’s Covid-19 vaccine to 12-to-17-year-olds, but the agency has held off while it looks into the risk of myocarditis, a rare heart condition.